TRxADE HEALTH Files 8-K on Material Definitive Agreement; Details Undisclosed
Ticker: SCNX · Form: 8-K · Filed: Jan 11, 2024 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Trxade Health, Inc (SCNX) |
| Form Type | 8-K |
| Filed Date | Jan 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001, $7.30 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: material-agreement, corporate-event, undisclosed-terms
TL;DR
**TRxADE HEALTH signed a big deal, but they're not telling us what it is yet.**
AI Summary
TRxADE HEALTH, INC. filed an 8-K on January 11, 2024, reporting an "Entry into a Material Definitive Agreement" on January 8, 2024. While the filing indicates a significant agreement, it does not disclose the specific details, parties involved, or financial terms of this agreement. This matters to investors because without the specifics, it's impossible to assess the potential positive or negative impact of this new material agreement on TRxADE HEALTH's future performance or stock value.
Why It Matters
This filing signals a potentially significant business development for TRxADE HEALTH, INC., but the lack of specific details makes it impossible for investors to evaluate its financial implications.
Risk Assessment
Risk Level: medium — The filing indicates a material agreement without providing any details, creating uncertainty and making it difficult for investors to assess potential risks or benefits.
Analyst Insight
A smart investor would wait for further disclosures from TRxADE HEALTH, INC. regarding the specifics of this material definitive agreement before making any investment decisions, as the current filing lacks crucial information to assess its impact.
Key Players & Entities
- TRxADE HEALTH, INC. (company) — the registrant filing the 8-K
- January 8, 2024 (date) — date of the earliest event reported (entry into material definitive agreement)
- January 11, 2024 (date) — date the 8-K was filed
Forward-Looking Statements
- TRxADE HEALTH, INC. will file another 8-K or press release in the near future to disclose the specific details of the material definitive agreement. (TRxADE HEALTH, INC.) — high confidence, target: 2024-02-11
FAQ
What is the specific nature of the "Material Definitive Agreement" entered into by TRxADE HEALTH, INC. on January 8, 2024?
The 8-K filing, dated January 11, 2024, indicates that TRxADE HEALTH, INC. entered into a "Material Definitive Agreement" on January 8, 2024, but it does not disclose the specific nature, terms, or parties involved in this agreement.
Why did TRxADE HEALTH, INC. file an 8-K on January 11, 2024?
TRxADE HEALTH, INC. filed the 8-K on January 11, 2024, to report an "Entry into a Material Definitive Agreement" that occurred on January 8, 2024, as required by SEC regulations for significant corporate events.
What items were reported in this 8-K filing by TRxADE HEALTH, INC.?
The 8-K filing by TRxADE HEALTH, INC. reported "Entry into a Material Definitive Agreement" under Item 1.01 and "Financial Statements and Exhibits" under Item 9.01, with the earliest event reported being January 8, 2024.
What is the business address and phone number of TRxADE HEALTH, INC. as stated in the filing?
According to the filing, TRxADE HEALTH, INC.'s business address is 2420 Brunello Trace, Lutz, Florida 33558, and its telephone number is (800) 261-0281.
What is the Commission File Number for TRxADE HEALTH, INC.?
The Commission File Number for TRxADE HEALTH, INC. is 001-39199, as stated in the 8-K filing.
Filing Stats: 814 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-01-11 17:25:42
Key Financial Figures
- $0.00001 — ch Registered Common Stock, par value $0.00001 per share MEDS The Nasdaq Stock Mar
- $7.30 — shares of the Company's common stock at $7.30 per share, which was comprised of: (i)
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex10-1.htm (EX-10.1) — 40KB
- 0001493152-24-002099.txt ( ) — 260KB
- meds-20240108.xsd (EX-101.SCH) — 3KB
- meds-20240108_lab.xml (EX-101.LAB) — 33KB
- meds-20240108_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRxADE HEALTH, INC. By: /s/ Suren Ajjarapu Name: Suren Ajjarapu Title: Chief Executive Officer Dated: January 11, 2024